6505--Contingency Contract (VA-26-00025745)

SOL #: 36C25626Q0332Combined Synopsis/Solicitation

Overview

Buyer

Veterans Affairs

Veterans Affairs, Department Of

256-NETWORK CONTRACT OFFICE 16 (36C256)

RIDGELAND, MS, 39157, United States

Place of Performance

Houston, TX

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Original Source

https://sam.gov/opp/e996a80e52e449a8804c9d27054b66c8/view

Timeline

Posted

Feb 6, 2026

Last Updated

Feb 11, 2026

Submission Deadline

Feb 16, 2026, 9:00 PM

Qualification Details

Fit reasons

NAICS alignment with historical contract wins in similar service areas.
Scope strongly matches core technical capabilities and delivery model.

Risks

Past performance thresholds may require one additional teaming partner.
Potential clarification needed on staffing minimums before bid/no-bid.

Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA), specifically the Michael E. Debakey VA Medical Center in Houston, TX, is seeking Emergency Contingency Services for Hazardous and Non-Hazardous Medication Compounding. This is an unrestricted combined synopsis/solicitation (RFQ) for a Firm-Fixed Price, Indefinite-Delivery-Indefinite-Quantity (IDIQ) contract. Quotes are due by February 16, 2026, at 3:00 PM CST.

Scope of Work

The contractor will provide comprehensive pharmacy medication compounding contingency services, including:

Provision of hazardous and non-hazardous agents, IV tubing, closed system drug transfer devices, and other necessary items.
Aseptic compounding of agents based on patient-specific orders.
Transportation of compounded orders via courier, overnight mail, or other means to ensure timely delivery.
Ensuring compounding, labeling, and beyond-use dating/expiration dating comply with USP 797, USP 800, and Federal Law.
Submission of current and future certification reports for sterile compounding areas and hoods.
Submission of the "VHA PBM Assessment Guide for Compounded Sterile Preparations within VAMCs and Outsourced Compounding Pharmacies" at the time of solicitation response and annually.

Contract Details

Contract Type: Firm-Fixed Price, Indefinite-Delivery-Indefinite-Quantity (IDIQ)
Period of Performance: One year from the date of award.
NAICS Code: 325412 (Pharmaceutical Preparation Manufacturing) with a small business size standard of 1,300 employees.
PSC: 6505 (Drugs And Biologicals)
Place of Performance: Michael E. Debakey VAMC, Building 100, Room 2A-290, 2002 Holcombe Blvd., Houston, TX 77030.

Eligibility & Evaluation

Set-Aside: This solicitation is unrestricted.
Evaluation Criteria: Lowest Price Technically Acceptable (LPTA), leading to a Firm-Fixed Priced Award.
Evaluation Factors: Technical (including Brand Name or Equal, and Contingency Plan) and Price.

Submission & Questions

Questions Due: All questions must be submitted via email to Contract Specialist Eugene Jackson (Eugene.Jackson2@va.gov) by February 10, 2026, at 12:00 PM CST.
Quotes Due: Quotes must be submitted electronically via email to Eugene.Jackson2@va.gov by February 16, 2026, at 3:00 PM CST.
Email Subject Line: "RFQ 36C25626Q0332–Pharmacy Contingency Contract for Hazardous and Non-Hazardous Compounding."
Required: Offerors must complete annual representations and certifications electronically via SAM.gov. Quotes must include a statement accepting the solicitation's terms and conditions or listing exceptions.